Kristin M. Voegtline1
Douglas A. Granger1,2,3*- 1Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
- 2Institute for Interdisciplinary Salivary Bioscience Research, Arizona State University, Tempe, AZ, USA
- 3Johns Hopkins University School of Nursing, Baltimore, MD, USA
The emergence of the interdisciplinary field of salivary bioscience has created opportunity for neonatal researchers to measure multiple components of biological systems non-invasively in oral fluids. The implications are profound and potentially high impact. From a single oral fluid specimen, information can be obtained about a vast array of biological systems (e.g., endocrine, immune, autonomic nervous system) and the genetic polymorphisms related to individual differences in their function. The purpose of this review is to describe the state of the art for investigators interested in integrating these unique measurement tools into the current and next generation of research on gonadal steroid exposure during the prenatal and neonatal developmental periods.
Introduction
The direction of research in the field of human development is being influenced by theoretical models that champion the study of individual differences using multi-level analyses of the confluence of prenatal, biological, behavioral, and social contextual forces [e.g., Ref. (1–4)]. Only recently have advances in salivary bioscience enabled investigators to test some of the core theoretical assumptions directly. Technical innovations now reveal that information may be obtained from oral fluid specimens about a broad array of physiologic systems including adrenal and gonadal steroids, inflammatory proteins of various types, infectious disease antibodies, environmental chemical exposures, metabolic markers, and genetic variability relevant to basic biological function, health, and disease. The attention that saliva has received as a biospecimen is largely due to the perceptions of sample collection as quick, uncomplicated, cost-efficient, and safe, and of salivary assays as reliable and accurate (see Table 1). The purpose of this report is to provide a roadmap for investigators interested in pushing cutting-edge integration of these measurement tools into the next generation of studies on gonadal steroid exposure and child development.
Table 1. Perceived “advantages” of oral fluids as a research specimen.
To date, the range of salivary analytes that have been integrated into developmental science has been restricted relative to the possibilities. The majority of studies with infants and children have primarily targeted cortisol as the salivary marker of choice given known associations with prenatal exposure [e.g., Ref. (5)], child behavior [e.g., Ref. (6, 7)], and in following with developmental origins theory, that early calibration of stress systems impacts health and development across the life course (8). However, the salivary proteome contains more than 1000 detectable analytes (9), including more understudied outputs of the hypothalamic–pituitary–gonadal (HPG) axis. Saliva contains measurable estrogens, androgens, and progesterone, yet few studies have collected oral fluid for this purpose in women during the antepartum and postpartum periods or in neonates (see Table 2); most have relied on serum.
Table 2. Gonadal steroid salivary analytes of interest to developmental science and past human studies utilizing salivary assessment in the prenatal and neonatal periods.
The extant literature on gonadal steroids focuses largely on levels observed during puberty and adulthood [see reviews (30, 31)]; we know far less about gonadal steroid exposure in early life and the majority of studies have relied on quantification from serum or plasma. However, not only do gonadal steroids of maternal origin cross the placental barrier and target the developing fetal brain (32, 33), but also birth marks a significant hormonal transition as the influence of the maternal endocrine milieu is withdrawn. In the first month following birth, infants exhibit a postnatal surge in gonadal steroids that parallel levels reached in adolescence, referred to as “mini-puberty” (34, 35). Further, steroid levels found in saliva, albeit lower in concentration, are correlated with serum constituents, particularly the free fraction which exerts physiological effects (12, 36).
To this end, we propose measurement considerations for oral fluid and applications of salivary analytes in studies of maternal and neonatal gonadal steroid activity for future investigation.
Salivary Measurement Considerations
Primer on Oral Fluid as a Biospecimen
“Saliva” is a composite of oral fluids secreted from many different glands. The source glands are located in the upper posterior area of oral cavity, lower area of the mouth between the cheek and jaw, and under the tongue. There are also many minor secretory glands in the lip, cheek, tongue, and palate. A small fraction of oral fluid (crevicular fluid) also comes from serum leakage in the cleft area between each tooth and its surrounding gums, or via leakage from serum due to mucosal injury or inflammation. Under healthy conditions, the contribution from serum is minimal but under conditions of mucosal or epithelial inflammation, serum constituents can represent a substantial portion of the analytes in the oral fluid pool. Each secretory gland produces a fluid that differs in volume, composition, and constituents [e.g., Ref. (37)]. Each source gland’s contribution to the pool of oral fluid varies (38). Oral fluid is water-like in composition and has a pH (acidity) range between 6 and 9. Foods and substances placed in the mouth are capable of changing specimen acidity because oral fluid has minimal buffering capacity. These changes in sample integrity have been shown to compromise measurement validity [e.g., Ref. (39)].
Gonadal hormones are exemplars of salivary analytes that reflect levels in general circulation, otherwise known as serum constituents. Serum constituents are transported into saliva either by filtration between the tight spaces between cells in the salivary glands or diffusion through cell membranes thereby enabling investigators to make interferences about systemic physiological states. Other analytes found in oral fluids are synthesized, stored, and released from the granules within the secretory cells of the saliva glands (i.e., enzymes, mucins, cystatins, histatins). Still others are components of humoral (antibodies, complement) immunity or compounds (cytokines) secreted by cells (neutrophils, macrophages, lymphocytes) of the mucosal immune system. An understanding of whether an analyte is transported into oral fluid by filtration or passive diffusion, secreted from salivary glands, or released or derived from cells locally in the oral mucosa is key to interpreting the meaning of individual differences in that measure.
The secretion of oral fluids is influenced by the day–night cycle; chewing movement of the mandibles; taste and smell; iatrogenic effects of medications that cause xerostomia (dry mouth); as well as medical interventions and conditions that affect saliva gland function. Saliva glands are directly innervated by parasympathetic and sympathetic nerves (40). Not surprisingly, activation of the ANS component of the psychobiology of the stress response affects saliva flow rates. The levels of salivary analytes that migrate into saliva from blood by filtration through the junctions between cells in the salivary gland (e.g., dehydroepiandrosterone-sulfate and other conjugated steroids) are influenced by the rate of saliva secretion [e.g., Ref. (41)].
The U.S. Centers for Disease Control notes that unless visibly contaminated with blood, oral fluid is not a class II biohazard. This statement has contributed to the perception that, among behaviorally scientists, saliva is safer to work with than blood. In reality, even under normative-healthy conditions, more than 250 species of bacteria are present in oral fluids (42). During upper respiratory infections, oral fluids are highly likely to contain agents of disease (43). An informal survey of biosafety policies at North American and UK academic institutions reveals a consensus that oral fluid specimens should be handled with universal precautions when employed for use in research or diagnostic applications.
Sample Collection
In the past, saliva collection devices have involved cotton-based absorbent materials [e.g., Ref. (44, 45)]. Placed in the mouth for 2–3 min, oral fluids rapidly saturate the cotton; the specimen is expressed into collection vials by centrifugation or compression [e.g., Ref. (46)]. Most of the time, this approach is convenient, simple, and time-efficient. However, when the absorbent capacity is large and sample volume is small, as is the case for neonates, the specimen absorbed can be diffusely distributed in the cotton fibers, making sample recovery problematic [e.g., Ref. (47)]. The process of absorbing oral fluid with cotton, and other materials, also has the potential to interfere with the immunoassay of several salivary analytes (48, 49).
Early studies with neonates employed serum assays modified for use with saliva by, among other things, requiring large saliva test volumes (200–400 μl). To collect sufficient test volumes, saliva flow was often stimulated using techniques that involved tasting (sugar crystals, citric acid drops) substances. When not used minimally and/or consistently, some of these methods are capable of changing immunoassay performance [e.g., Ref. (39)]. Indirectly, stimulants also influence measurement of the levels of salivary analytes that are dependent on saliva flow rate (dehydroepiandrosterone-sulfate, DHEA-S). Saliva collected from neonates requires a technique that uses an absorbent material (50). Current collection methods use oral swabs, which are ideal for neonates and infants. This is because the swab can be narrower in diameter, particularly well-suited for the small mouths of neonates, and the material is non-toxic and durable for use with older infants that may gum the device during collection.
Sample Handling, Transport, and Storage
Typically, once specimens are collected, they should be kept cold or frozen. Refrigeration prevents degradation of some salivary analytes and restricts the activity of proteolytic enzymes and growth of bacteria. We explored the impact of bacteria-related issues on the measurement of salivary analytes. Significant declines occur in the levels of some salivary analytes when samples are stored at RT or 4°C in comparison to −60°C after 96 h (51). Whembolua and colleagues (52) showed that changes in salivary analytes related to storage temperatures were associated with growth in bacteria, but not baseline bacteria levels. The way in which samples are handled, stored, and transported after collection has the potential to influence sample integrity and measurement validity. Our recommendation is conservative. After collection, saliva samples should be kept frozen. If freezing is not possible, then at a minimum, samples should be kept cold (on ice or refrigerated) until they can be frozen that day. Repeated freeze–thaw cycles should be avoided with saliva samples. In our experience, DHEA, estradiol, and progesterone are very sensitive to freeze–thaw, whereas testosterone is robust (up to at least three cycles). This position is consistent with aliqouting and archiving frozen samples in anticipation that biotechnology advances will enable different markers to be assayed in the future. It should also be noted that some salivary analytes may require specimens to be directly collected into storage vials that are chilled [Ref. (53); but see Ref. (54)] or treated with neuropeptidase inhibitors (such as EDTA or aprotinin) to minimize rapid degradation (55, 56). For large-scale national surveys, investigators working in remote areas [e.g., Ref. (57, 58)], or patients collecting samples at home (59), freezing and shipping these frozen samples can be logistically complex and cost-prohibitive. Under special circumstances, saliva may not be the biospecimen of choice; alternatively, the degree of the impact of the handling and storage conditions should be documented by pilot work.
Contaminants in Oral Fluid
Most of the time, to meaningfully index systemic biological activity, quantitative estimates of an analyte (e.g., hormone) in saliva must be highly correlated with the levels measured in serum. The magnitude of this serum–saliva association depends, in part, on consistency in the processes (27) used to transport circulating molecules into oral fluids. When the integrity of diffusion or filtration is compromised, the level of the serological marker in saliva will be affected because of the differential concentration gradient. It also depends on the presence of contaminants in oral fluid, which investigators should be aware of, control for if possible, and in all cases, document.
Blood and blood products can leak into oral fluids via burns, abrasions, or cuts to the cheek, tongue, or gums. Blood in oral fluid is more prevalent among individuals who suffer from poor oral health (i.e., open sores, periodontal disease, gingivitis), endure certain infectious diseases [e.g., HIV; Ref. (60)], and engage in behavior known to influence oral health negatively [e.g., tobacco use; Ref. (61)]. Saliva contaminated with blood will present varying degrees of yellow-brownish hue (62). Utilizing salivary transferrin as a surrogate marker, our bench (spiking blood into saliva) and experimental studies (inducing microinjury to the mouth by brushing the gums) have shown the degree of blood contamination needed to influence salivary hormone levels. Differences among the lengths of the effect (10–45 min) depend on the salivary analyte of interest (62–64). Gonadal steroids appear to be more susceptible to blood leakage in the oral cavity, with testosterone in particular showing an increase in response to microinjury in the oral cavity (62). At the same time, <0.1% of statistical outliers (+2.5 SDs) in salivary hormone distributions have been shown to be associated with elevated transferrin (65). Thus, blood contamination of oral fluid was a characteristic of individual specimens and not consistently detected within all samples from individuals. In studies of neonates and children, blood contamination is rare (65), however, studies of antepartum women who may present oral health risk should take heed to document and control for blood contamination.
A more universal concern, and one especially relevant in neonates, is contamination of samples from particulate matter and interfering substances placed in the mouth. Breastmilk, formula, and solids introduced later in infancy create residue in the oral cavity after drinking or eating may include particulate matter, change salivary pH or composition (viscosity), and/or contain substances (e.g., bovine hormones, enzymes) that cross-react in immune- or kinetic-reaction assays. Given the variation of infant feeding schedules and the difficulty in restricting intake, particularly when young infants are fed on demand, we recommend a simple solution: children should not be fed and adults should refrain from eating and drink with exception of water within the 20-min prior to sample donation. For repeated measure designs, saliva collection should be carefully planned and scheduled, and prior feedings noted.
Prescription and over-the-counter medications are also known contaminants to oral fluid, including those that are applied intranasally, inhaled or applied as oral topicals (e.g., teething gels). These substances have the potential to change saliva composition due to residue left by their use in the oral cavity, cross-reaction with antibody–antigen binding in immunoassays, and reduced salivary flow rate (66, 67). Confounding the effort to control for the potential effects of medications on salivary analytes is the possibility that the condition for which the medication is prescribed or taken may also influence individual differences in the analytes levels or activity (68). Few behaviorally oriented studies that involve salivary analytes have comprehensively documented medication usage. In one study of infants, nearly half (44%; n = 852) of the 6-month-old infants were given acetaminophen in the 48 h prior to saliva collection. Acetaminophen was shown to attenuate cortisol reactivity (69); implications for gonadal steroids remain unknown.
The lack of normative data and the wide-ranging individual differences in salivary analytes levels make case-by-case exclusion of samples from individuals taking any particular medication questionable (unless the deviation is obviously not physiologically plausible). Of course, the simplest approach would be to exclude anyone who is taking any medication from participation in research. This includes sampling from neonates of breastfeeding mothers who are themselves on a medication. Although appropriate from the perspective of rigorous experimental design, this conservative approach yields no information that may help us develop our knowledge of which medications are, or are not, problematic. Also, in studies of some specialized populations (e.g., pregnant patients with physical or mental illnesses), prescription medication use is so highly prevalent that it is considered normative. Withholding treatment raises ethical questions while excluding those taking medications increases the potential that findings may be confounded by selection bias. Future work is encouraged to document participant medication use and evaluate associations with steroid levels measured in saliva to build knowledge and document pharmaceutical contamination effects or lack thereof.
Applications of Salivary Analytes in Studies of Maternal and Neonatal Gonadal Steroid Activity
Dependent on the nature of the research question, several sampling schemes are common for studies involving oral fluid. At the individual level, a single sample may be collected to index basal level, or multiple samples may be collected across the course of the day to capture diurnal rhythm. Concurrent sampling of a dyad is an additional scheme designed to evaluate associative relations over time. In further discussion of each sampling scheme below, we have embedded existing research drawn from Table 2 utilizing saliva to index maternal and neonatal gonadal steroid levels to encourage additional reading. Existing studies are relatively scant, yet saliva offers a wide array of application as a minimally invasive, accurate, and cost-effective approach; we offer suggestions for areas of future investigation with salivary analytes.
Basal or “Trait-Like” Levels
The basal level or activity of an analyte represents the stable state of the host during a resting period. One approach to assessing basal levels has been to sample early in the morning before the events of the day are able to contribute variation or specify a restricted time window for collection to reduce variation between participants [e.g., ±1200 h, Ref. (12)].
Single sampling is the most common approach for saliva collection, and the majority of studies referenced in Table 2 have employed this scheme. While overall the literature on salivary steroids during pregnancy and in the postpartum is lacking, studies examining estriol levels among antepartum women are most common (see Table 2). Estriol monitoring via saliva has been utilized as a clinical tool to assess the vitality of fetoplacental unit and a marker of preterm birth (17, 18). For this analyte, repeated measures of the “basal” level have been employed to detect atypical change [e.g., Ref. (18); weekly sampling from 22 weeks GA until birth]. As seen, the studies by Marrs and colleagues (11) as well as the more recent Hampson and colleagues (12) offer the most comprehensive report on gonadal steroids concentrations in antepartum and postpartum women and in comparison to serum, though limited to a single measurement during the third trimester of pregnancy. Future work is needed to elucidate reference values for gonadal steroids earlier in gestation, to evaluate normative endocrine changes of pregnancy and serve as a clinical tool for diagnosis of adrenal disorders during pregnancy.
We are only aware of a single study measuring neonatal salivary testosterone basal levels; findings revealed a positive association between salivary testosterone and neonatal health problems as well as growth delays among a high-risk preterm sample (21). A multitude of studies have explored neonatal cortisol reactivity, but more research is needed to understand the significance of the gonadal hormonal transition surrounding birth. Beyond the neonatal period, a handful of studies have sampled gonadal steroids to characterize “mini-puberty” observed during early infancy (70, 71). Testosterone levels of male infants peak between 1 and 3 months of age, and female infants show a spike between 2 and 4 months in follicle stimulating hormone (71, 72). The physiological relevance of this phenomenon, which exhibits universality across mammalian species, is theorized to activate sexual dimorphisms in the brain (72), remains underexplored to date. These analyses relied on single measures at varying ages to identify peak levels.
While a start, a single-time point measure of salivary analytes (other than invariant genetic polymorphisms), except under very unique circumstances, is unlikely to yield meaningful results for “basal levels” given that salivary analytes may vary depending on the inherent moment-to-moment, diurnal and/or monthly variation in their production/release, rate of their metabolism/degradation, and sensitivity to environmental influence. Given these issues, in combination with the moving target gonadal steroids present during the antepartum and neonatal/infant periods during which physiological shifts in hormone concentration are expected, cluster sampling for a series of three consecutive days is recommended. The association of salivary analyte measurements across days is likely to be stronger for some salivary analytes than others yet employing cluster sampling enhances overall reliability of the estimates by aggregating (e.g., average assay results or physically pool specimens). The minimally invasive nature of oral fluid collection is ideal for cluster sampling. Future studies are needed to describe the observed surge in gonadal steroids during infancy, investigate sex differences, and test predictive associations linking gonadal steroid activation to behavior.
Diurnal Rhythm
An important component of variability within and between individuals in salivary analyte levels is the diurnal rhythm of production [e.g., Ref. (73, 74)]. Most salivary hormone levels (e.g., cortisol, testosterone) are high in the morning, decline before noon, and then decline more slowly in the afternoon and evening hours (75). The non-linear nature of these patterns requires multiple sampling time points to create adequate statistical models (76).
The diurnal rhythm of gonadal steroid output in antepartum or postpartum women remains largely unexplored to date. There is evidence that the diurnal pattern is retained during pregnancy for other hormone outputs such as cortisol (77–79). For neonates, recent evidence suggests that in the first postnatal week the adrenal circadian rhythm becomes unsynchronized with clock time, peaking in late afternoon or at a time parallel to the birth time (80). The typical 24-h rhythm is generally not observed until after a few months for cortisol production, potentially coinciding with stabilization of the sleep–wake cycle. One study of salivary 17-OH progesterone indexed in neonates on the first or second day of life confirmed this, finding no evidence of a diurnal pattern (22). In a second cross sectional study designed to establish diurnal reference values for salivary progesterone and 17-OH progesterone, a diurnal pattern was observed among neonates <4 weeks age (n = 13, age range = 4–27 days) for 17-OH progesterone but not progesterone (23). Less is known about at what age gonadal steroids begin to show a characteristic diurnal rhythm; future studies documenting this would represent a considerable contribution to the literature, particularly during this rapid phase of development.
Analytical techniques that have been used to model individual differences in diurnal rhythm range from average levels, to focusing specifically on the awakening component of the overall pattern, to estimating AUC. Growth curve modeling (81) may be an optimal method of parameterizing individual differences because: (1) it allows the level and slope of the diurnal rhythm to be examined in the same model; (2) unsystematic error variance is partialed out of the “true” score; (3) the presence of individual differences in the diurnal rhythm is statistically tested; (4) predictors of the diurnal rhythm are related to level and slope in the same model (partialing out the effects of one another); and (5) changes in the variance estimates of the level and slope act as indicators of the overall contribution of the predictors [e.g., Ref. (81, 82)].
Associative Relations of Salivary Analytes between Dyads
Physiological attunement or concordance of maternal and fetal hormones is documented before birth, in utero. For example, maternal prenatal testosterone serum levels are correlated with fetal levels ascertained from samples of amniotic fluid for both sexes (83). Further, women carrying male fetuses show higher testosterone concentrations relative to those carrying females (84) suggesting bidirectionality of observed associative relations.
Although recognized that in the postpartum period gonadal steroids may be decreasing in concentration among women while concurrently increasing among neonates, postnatal dyadic attunement of gonadal steroids remains an underexplored, yet promising, avenue for future research. The study noted in Table 2 that indexed neonatal salivary testosterone did find a positive correlation between testosterone levels in neonates and mothers in the first week after birth (21). Examining predictive associations from maternal levels during pregnancy to neonatal levels in the postpartum would also be of interest; for example, is there a greater or faster increase in gonadal steroid activity among neonates that experience more significant withdrawal from the maternal prenatal endocrine context (i.e., exposure to higher concentrations in the prenatal period).
The examination of associative relations need not be constrained to the dyad; at the individual level, this scheme carries over to studies exploring the coaction of two or more hormones. A single saliva sample of sufficient volume may be assayed for multiple analytes. For example, there is known functional cross-talk occurring between the HPG and HPA axes where gonadal steroids are postulated to induce a negative feedback loop in HPA reactivity (85). Gonadal steroids have also been theorized to stimulate oxytocin and in turn promote maternal behaviors in the postpartum period among mammals (86), as well as modulate immune and autoimmune response in general (87, 88). A dual systems approach that examines associative relations among two or more hormonal outputs (e.g., cortisol, oxytocin, SIgA) holds great promise for a deeper understanding of hormonal coaction during the antepartum and postpartum periods as well as calibration of early gonadal steroid activity in neonates and infants.
Typically, examination of relationships between two continuous variables involves the use of a summary statistic, such as a correlation; however, this is not always the most advantageous method. Nagin and Tremblay (89) used a model that jointly estimates growth mixture models for two distinct but related measurement series. The joint probabilities generated allow investigators to characterize the relationship between two dependent variables as they unfold over a specified period of time. Physiological attunement between members of the mother–child dyad appears to be a worthwhile application for this dual trajectory model.
Conclusion
Parturition marks a host of physiological adaptations associated with changing environments; systems of respiration, circulation, homeostasis, and state regulation are just a few examples. While widely acknowledged that endocrine factors play an important role in this transition, the interrelationship of mother and infant gonadal steroids during this transition is not well understood. Beyond organizational effects, we know even less about how the transient activation of gonadal steroids in early postnatal life serves to differentiate child behavior and development.
As prenatal and neonatal gonadal steroid exposure can be reliably ascertained from saliva, and collected in a non-invasive manner particularly well-suited for research designs involving neonates and infants, oral fluid may become the biospecimen of choice for students of early human development. The purpose of this review was to provide a conceptual and tactical roadmap for investigators interested in integrating these measurement tools surrounding saliva into research on gonadal steroid exposure and health and human development. We continue to believe that the implications of the information divulged via this research will have a profound impact on developmental science in general, and the study of neonatal health and development in particular.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
Special thanks are due to the many faculty collaborators (Clancy Blair, the Family Life Project investigators), junior colleagues (Leah Hibel, Katie T. Kivlighan, Elizabeth A. Shirtcliff, and Amanda Harmon), and biotechnicians (Eve B. Schwartz, Vincent Nelson, Mary Curran, and Becky Zavacky) who have facilitated various aspects of the studies presented herein. In the interest of full disclosure, Douglas A. Granger is the founder and Chief Scientific and Strategy Advisor at Salimetrics LLC and Salivabio LLC and these relationships are managed by the policies of the committee on conflict of interest at Johns Hopkins University School of Medicine, and the Arizona State University Office of Research Integrity and Adherence.
References
1. Belsky J. The determinants of parenting: a process model. Child Dev (1984) 55:83–96. doi: 10.2307/1129836
2. Belsky J. Differential susceptibility to rearing influence. In: Ellis BJ, Bjorklund DF, editors. Origins of the Social Mind: Evolutionary Psychology and Child Development. New York: Guildford Press (2005). p. 139–63.
3. Boyce WT, Ellis BJ. Biological sensitivity to context: I. An evolutionary-developmental theory of the origins and functions of stress reactivity. Dev Psychopathol (2005) 17:271–301. doi:10.1017/S0954579405050145
4. Johnson SB, Riley AW, Granger DA, Riis J. The science of early life toxic stress for pediatric practice and advocacy. Pediatrics (2013) 131:319–27. doi:10.1542/peds.2012-0469
5. O’Connor TG, Bergman K, Sarkar P, Glover V. Prenatal cortisol exposure predicts infant cortisol response to acute stress. Dev Psychobiol (2012) 55(2):145–55. doi:10.1002/dev.21007
6. Ramsay D, Lewis M. Reactivity and regulation in cortisol and behavioral responses to stress. Child Dev (2003) 74(2):456–64. doi:10.1111/1467-8624.7402009
7. Stansbury K, Gunnar MR. Adrenocortical activity and emotion regulation. Monogr Soc Res Child Dev (1994) 59(2–3):108–34. doi:10.1111/j.1540-5834.1994.tb01280.x
8. Gluckman P, Hanson M. The conceptual basis for the developmental origins of health and disease. In: Gluckman P, Hanson M, editors. Developmental Origins of Health and Disease. New York: Cambridge University Press (2006). p. 33–50.
9. Hu S, Loo JA, Wong DT. Human saliva proteome analysis. Ann N Y Acad Sci (2007) 1098:323–9. doi:10.1196/annals.1384.015
10. Darne J, McGarrigle HHG, Lachelin GC. Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: spontaneous labour at term is preceded by a rise in the saliva oestriol: progesterone ratio. BJOG (1987) 94:227–35. doi:10.1111/j.1471-0528.1987.tb02359.x
11. Marrs CR, Ferraro DP, Cross CL. Salivary hormones and parturition in healthy, primigravid women. Int J Gynecol Obstet (2007) 99:59–60. doi:10.1016/j.ijgo.2007.03.032
12. Hampson E, Phillips SD, Soares CN, Steiner M. Steroid concentrations in antepartum and postpartum saliva: normative values in women and correlations with serum. Biol Sex Differ (2013) 4:7. doi:10.1186/2042-6410-4-7
13. Kundu N, Novak N, Petersen LP. Salivary unconjugated estriol levels in normal third trimester pregnancy-direct correlation with serum levels. Steroids (1983) 41:145–53. doi:10.1016/0039-128X(83)90003-X
14. Lechner W, Heim K, Zech J, Daxenbichler G, Marth C. The relation between saliva estriol levels in pregnancy and infant birth weight. Arch Gynecol Obstet (1987) 241:9–12. doi:10.1007/BF00931435
15. Lewis PR, Galvin PM, Short RV. Salivary oestriol and progesterone concentrations in women during late pregnancy, parturition and the puerperium. J Endocrinol (1987) 115:177–81. doi:10.1677/joe.0.1150177
16. Scott EM, Thomas A, McGarrigle HHG, Lachelin GC. A comparison of serial ultrasound measurements of fetal adrenal glands with maternal plasma and saliva oestriol and progesterone levels in normal pregnancy. J Obstet Gynecol (1991) 11:381–5. doi:10.3109/01443619109013573
17. McGregor JA, Jackson GM, Lachelin GC, Goodwin TM, Artal R, Hastings C, et al. Salivary estriol as risk assessment for preterm labor: a prospective trial. Am J Obstet Gynecol (1995) 173:1337–42.
18. Heine RP, McGregor JA, Goodwin TM, Artal R, Hayashi RH, Robertson PA, et al. Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol (2000) 96:490–7. doi:10.1016/S0029-7844(00)01004-8
19. Hedriana HL, Munro CJ, Eby-Wilkens EM, Lasley BL. Changes in rates of salivary estriol increases before parturition at term. Am J Obstet Gynecol (2001) 184:123–30. doi:10.1067/mob.2001.108338
20. Klebanoff MA, Meis PJ, Dombrowski MP, Zhao Y, Moawad AH, Northen A, et al. Salivary progesterone and estriol among pregnant women treated with 17-α-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol (2008) 199:506–e1. doi:10.1016/j.ajog.2008.03.003
21. Cho JI, Carlo WA, Su X, McCormick KL. Associations between salivary testosterone and cortisol levels and neonatal health and growth outcomes. Early Hum Dev (2012) 88:789–95. doi:10.1016/j.earlhumdev.2012.05.002
22. Klug I, Dressendörfer R, Strasburger C, Kühl GP, Reiter HL, Reich A, et al. Cortisol and 17-hydroxyprogesterone levels in saliva of healthy neonates. Neonatology (2000) 78:22–6. doi:10.1159/000014242
23. Gröschl M, Rauh M, Dörr HG. Circadian rhythm of salivary cortisol, 17α-hydroxyprogesterone, and progesterone in healthy children. Clin Chem (2003) 49:1688–91. doi:10.1373/49.10.1688
24. Priya B, Mustafa MD, Guleria K, Vaid NB, Banerjee BD, Ahmed RS. Salivary progesterone as a biochemical marker to predict early preterm birth in asymptomatic high-risk women. BJOG (2013) 120:1003–11. doi:10.1111/1471-0528.12217
25. Few JD, Paintin DB, James VHT. The relation between aldosterone concentrations in plasma and saliva during pregnancy. BJOG (1986) 93:928–32. doi:10.1111/j.1471-0528.1986.tb08010.x
26. Tabak LA. Point-of-care diagnostics enter the mouth. Ann N Y Acad Sci (2007) 1098:7–14. doi:10.1196/annals.1384.043
28. Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci (2007) 1098:51–103. doi:10.1196/annals.1384.037
29. U.S. Department of Health and Human Services. Oral Health in America: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health (2000). 74–94 p.
30. Sisk CL, Zehr JL. Pubertal hormones organize the adolescent brain and behavior. Front Neuroendocrinol (2005) 26(3):163–74. doi:10.1016/j.yfrne.2005.10.003
31. Pike CJ, Carroll JC, Rosario ER, Barron AM. Protective actions of sex steroid hormones in Alzheimer’s disease. Front Neuroendocrinol (2009) 30(2):239–58. doi:10.1016/j.yfrne.2009.04.015
32. McEwen B, Davis P, Parsons B, Pfaff D. The brain as a target for steroid hormone action. Annu Rev Neurosci (1979) 2:65–112. doi:10.1146/annurev.ne.02.030179.000433
33. Peper J, Koolschijn C. Sex steroids and the organization of the human brain. J Neurosci (2012) 32:6745–6. doi:10.1523/JNEUROSCI.1012-12.2012
34. Forest M, Cathiard A, Bertrand J. Evidence of testicular activity in early infancy. J Clin Endocrinol (1973) 37:148–51. doi:10.1210/jcem-37-1-148
35. Forest M, Sizonenko P, Cathiard A, Bertrand J. Hypophyso-gonadal function in humans during the first year of life. J Clin Invest (1974) 53:819–28. doi:10.1172/JCI107621
36. Gröschl M. Current status of salivary hormone analysis. Clin Chem (2008) 54:1759–69. doi:10.1373/clinchem.2008.108910
37. Veerman ECI, van den Keijbus PAM, Vissink A, Nieuw Amerongen AV. Human glandular salivas: their separate collection and analysis. Eur J Oral Sci (1996) 104:346–52. doi:10.1111/j.1600-0722.1996.tb00090.x
38. Nieuw Amerongen AVM, Bolscher JGM, Veerman ECI. Salivary mucins: protective functions in relation to their diversity. Glycobiology (1995) 5:733–40. doi:10.1093/glycob/5.8.733
39. Schwartz EB, Granger DA, Susman EJ, Gunnar MR, Laird B. Assessing salivary cortisol in studies of child development. Child Dev (1998) 69:1503–13. doi:10.2307/1132128
40. Garrett JR. The proper role of nerves in salivary secretion: a review. J Dent Res (1987) 66:387–97. doi:10.1177/00220345870660020201
41. Kugler J, Hess M, Haake D. Secretion of salivary immunoglobulin A in relation to age, saliva flow, mood states, secretion of albumin, cortisol, and catecholamines in saliva. J Clin Immunol (1992) 12:45–9. doi:10.1007/BF00918272
42. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, et al. Bacterial diversity in human subgingival plaque. J Bacteriol (2001) 183:3770–83. doi:10.1128/JB.183.12.3770-3783.2001
43. Scannapieco FA, Papandonatos GD, Dunford RG. Associations between oral conditions and respiratory disease in a national sample survey population. Ann Periodontol (1998) 3:251–6. doi:10.1902/annals.1998.3.1.251
44. Dabbs JM Jr. Salivary testosterone measurements: collecting, storing, and mailing saliva samples. Physiol Behav (1991) 49:815–7. doi:10.1016/0031-9384(91)90323-G
46. Gunnar M, Mangelsdorf S, Larson M, Hertsgaard L. Attachment, temperament, and adrenocortical activity in infancy: a study of psychoendocrine regulation. Dev Psychol (1989) 3:355–63. doi:10.1037/0012-1649.25.3.355
47. Harmon AG, Hibel LC, Rumyansteva O, Granger DA. Measuring salivary cortisol in studies of child development: watch out – what goes in my not come out of saliva collection devices. Dev Psychobiol (2007) 49:495–500. doi:10.1002/dev.20231
48. Gröschl M, Rauh M. Influence of commercial collection devices for saliva on the reliability of salivary steroids analysis. Steroids (2006) 71:1097–100. doi:10.1016/j.steroids.2006.09.007
49. Shirtcliff EA, Granger DA, Schwartz EB, Curran MJ. Use of salivary biomarkers in biobehavioral research: cotton based sample collection methods can interfere with salivary immunoassay results. Psychoneuroendocrinology (2001) 26:165–73. doi:10.1016/S0306-4530(00)00042-1
50. Granger DA, Kivlighan KT, Fortunato C, Harmon AG, Hibel LC, Schwartz EB, et al. Integration of salivary biomarkers into developmental and behaviorally-oriented research: problems and solutions for collecting specimens. Physiol Behav (2007) 92:583–90. doi:10.1016/j.physbeh.2007.05.004
51. Schwartz EB, Eppihimer L, Nelson VJ, Granger DA. Effects of sample storage temperature on the measurement of salivary analytes: degradation of testosterone, estradiol, and progesterone. Poster presented at the annual meeting of the American Association for Clinical Chemistry, Orlando, FL. Clin Chem (2005) 51(6 Suppl):A2–261.
52. Whembolua GL, Granger DA, Singer S, Kivlighan KT, Marguin JA. Bacteria in the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav (2006) 49:478–83. doi:10.1016/j.yhbeh.2005.10.005
53. Carter CS, Pournajafi-Nazarloo H, Kramer KM, Ziegler TE, White-Traut R, Bello D, et al. Oxytocin: behavioral associations and potential as a salivary biomarker. Ann N Y Acad Sci (2007) 1098:312–22. doi:10.1196/annals.1384.006
54. Horvat-Gordon M, Granger DA, Schwartz EB, Nelson V, Kivlighan KT. Oxytocin is not a valid biomarker when measured in saliva by immunoassay. Physiol Behav (2005) 16:445–8. doi:10.1016/j.physbeh.2005.01.007
55. Dawidson I, Blom M, Lundeberg T, Theodorsson E, Angmar-Mansson B. Neuropeptides in the saliva of healthy subjects. Life Sci (1997) 60:269–78. doi:10.1016/S0024-3205(96)00627-3
56. Santavirta N, Konttinen YT, Tornwall J, Segerberg M, Santavirta S, Matucci-Cerinic M, et al. Neuropeptides of the autonomic nervous system in Sjogren’s syndrome. Ann Rheum Dis (1997) 56:737–40. doi:10.1136/ard.56.12.737
57. Beall CM, Worthman CM, Stallings J, Strohl KP, Brittenham GM, Barragan M. Salivary testosterone concentration of Aymara men native to 3600 m. Ann Hum Biol (1992) 19:67–78. doi:10.1080/03014469200001932
58. Flinn MV, England BG. Childhood stress and family environment. Curr Anthropol (1995) 36:854–66. doi:10.1086/204444
59. Raff H, Homar PJ, Skoner DP. New enzyme immunoassay for salivary cortisol. Clin Chem (2003) 49:203–4. doi:10.1373/49.1.203
60. Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med (1998) 27:176–9. doi:10.1111/j.1600-0714.1998.tb01936.x
61. Reibel J. Tobacco and oral diseases. Update on the evidence, with recommendations. Med Princ Pract (2003) 1(Suppl):22–32. doi:10.1159/000069845
62. Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M, Shirtcliff EA. Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav (2004) 46:39–46. doi:10.1016/j.yhbeh.2004.01.006
63. Kivlighan KT, Granger DA, Schwartz EB. Blood contamination and the measurement of salivary progesterone and estradiol. Horm Behav (2005) 47:367–70. doi:10.1016/j.yhbeh.2004.12.001
64. Schwartz EB, Granger DA. Transferrin enzyme immunoassay for quantitative monitoring of blood contamination in saliva. Clin Chem (2004) 50:654–6. doi:10.1373/clinchem.2003.028266
65. Granger DA, Cicchetti D, Rogosch F, Hibel LC, Teisl M, Flores E. Blood contamination in children’s saliva: prevalence, stability, and impact on the measurement of salivary cortisol, testosterone, and dehydroepiandrosterone. Psychoneuroendocrinology (2007) 32:724–33. doi:10.1016/j.psyneuen.2007.05.003
67. Sreebny LM, Schwartz SS. A reference guide to drugs and dry mouth – 2nd edition. Gerodontology (1997) 14:33–47. doi:10.1111/j.1741-2358.1997.00033.x
68. Granger DA, Hibel LC, Fortunato CK, Kapelewski CH. Medication effects on salivary cortisol: tactics and strategy to minimize impact in behavioral and developmental science. Psychoneuroendocrinology (2009) 34:1437–48. doi:10.1016/j.psyneuen.2009.06.017
69. Hibel LC, Granger DA, Kivlighan KT, Blair C, FLP Investigators. Individual differences in salivary cortisol: associations with common over-the-counter and prescription medication status in infants and their mothers. Horm Behav (2006) 50:293–300. doi:10.1016/j.yhbeh.2006.03.014
70. Hines M. Gender development and the human brain. Annu Rev Neurosci (2011) 34:69–88. doi:10.1146/annurev-neuro-061010-113654
71. Lamminmaki A, Hines M, Kuiri-Hanninen T, Kilpelainen L, Dunkel L, Sankilampi U. Testosterone measured in infancy predicts subsequent sex-typed behavior in boys and in girls. Horm Behav (2012) 61:611–6. doi:10.1016/j.yhbeh.2012.02.013
72. Quigley C. Editorial: the postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome. J Clin Endocrinol Metab (2002) 87:24–8. doi:10.1210/jcem.87.1.8265
73. Gunnar MR, Vasquez D. Low cortisol and a flattening of expected daytime rhythm: potential indices of risk in human development. Dev Psychopathol (2001) 13:515–38. doi:10.1017/S0954579401003066
74. Smyth JM, Ockenfels MC, Gorin AA, Cately D, Porter LS, Kirschbaum C, et al. Individual differences in the diurnal cycle of cortisol. Psychoneuroendocrinology (1997) 22:89–105. doi:10.1016/S0306-4530(96)00039-X
75. Nelson RJ. An Introduction to Behavioral Endocrinology. Sunderland, MA: Sinauer Associates (1995).
76. Hellhammer J, Fries E, Schweusthal OW, Schlotz W, Stone AA, Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components. Psychoneuroendocrinology (2007) 32:80–6. doi:10.1016/j.psyneuen.2006.10.005
77. Allolio B, Hoffmann J, Linton EA, Winkelmann W, Kusche M, Schulte HM. Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol (1990) 33:279–89. doi:10.1111/j.1365-2265.1990.tb00492.x
78. de Weerth C, Buitelaar JK. Cortisol awakening response in pregnant women. Psychoneuroendocrinology (2005) 30:902–7. doi:10.1016/j.psyneuen.2005.05.003
79. Kivlighan KT, DiPietro JA, Costigan KA, Laudenslager ML. Diurnal rhythm of cortisol during late pregnancy: associations with maternal psychological well-being and fetal growth. Psychoneuroendocrinology (2008) 33:1225–35. doi:10.1016/j.psyneuen.2008.06.008
80. Iwata O, Okamura H, Saitsu H, Saikusa M, Kanda H, Eshima N, et al. Diurnal cortisol changes in newborn infants suggesting entrainment of peripheral circadian clock in utero and at birth. J Clin Endocrinol Metab (2013) 98:E25–32. doi:10.1210/jc.2012-2750
81. McArdle JJ, Bell RQ. An introduction to latent growth models for developmental data analysis. In: Little TD, Schnabel KU, Baumert J, editors. Modeling Longitudinal and Multiple-Group Data: Practical Issues, Applied Approaches, and Specific Examples. Hillsdale, NJ: Lawrence Erlbaum Associates (2000). p. 69–107.
82. McArdle JJ, Nesselroade J. Using multivariate data to structure developmental change. In: Cohen SH, Reese HW, editors. Life-Span Developmental Psychology. Hillsdale, NJ: Lawrence Erlbaum Associates (1994). p. 223–67.
83. Gitau R, Adams D, Risk N, Glover V. Fetal plasma testosterone correlates positively with cortisol. Arch Dis Child Fetal Neonatal Ed (2005) 90:F166–9. doi:10.1136/adc.2004.049320
84. Meulenberg PMM, Hofman JA. Maternal testosterone and fetal sex. J Steroid Biochem Mol Biol (1991) 39(1):51–4. doi:10.1016/0960-0760(91)90012-T
85. Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J Neuroendocrinol (2002) 14:506–13. doi:10.1046/j.1365-2826.2002.00798.x
86. Pedersen CA. Oxytocin control of maternal behavior. Regulation by sex steroids and offspring stimuli. Ann N Y Acad Sci (1997) 807:126–45. doi:10.1111/j.1749-6632.1997.tb51916.x
87. Grossman CJ. Interactions between the gonadal steroids and the immune system. Science (1985) 227:257–61. doi:10.1126/science.3871252
88. Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol (2003) 176:293–304. doi:10.1677/joe.0.1760293
Keywords: saliva analytes, saliva collection, testosterone, DHEA, estrogen, neonatal, analytical strategy
Citation: Voegtline KM and Granger DA (2014) Dispatches from the interface of salivary bioscience and neonatal research. Front. Endocrinol. 5:25. doi: 10.3389/fendo.2014.00025
Received: 20 December 2013; Accepted: 17 February 2014;
Published online: 04 March 2014.
Edited by:
Rebecca C. Knickmeyer, University of North Carolina at Chapel Hill, USAReviewed by:
Giorgio Radetti, General Hospital of Bolzano, ItalyS. F. Ahmed, Royal Hospital for Sick Children, UK
Copyright: © 2014 Voegtline and Granger. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Douglas A. Granger, Institute for Interdisciplinary Salivary Bioscience Research, Arizona State University, ISTB 1 Building, 550 Orange Street, Tempe, AZ 85287-3604, USA e-mail: douglas.granger@asu.edu